WealthPLAN Partners’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
KGAMU
6CM
WealthPLAN Partners's CDLX Position: Q3 2020 in Review
WealthPLAN Partners sold out of Cardlytics (CDLX) in Q3 2020, closing a stake of 300 shares — an estimated $240K sold.
WealthPLAN Partners first reported a position in CDLX in Q4 2019 and held it in 2 quarters. The position peaked at $281K in Q4 2019. 164 funds tracked by Wall St. Rank hold CDLX as of Q3 2020.
- WealthPLAN Partners reported no remaining Cardlytics position as of Q3 2020 after selling out during the quarter.
- WealthPLAN Partners sold 300 Cardlytics shares in Q3 2020, an estimated $240K.
- WealthPLAN Partners first reported a position in Cardlytics in Q4 2019 and held it in 2 quarters.
- WealthPLAN Partners's Cardlytics position peaked at $281K in Q4 2019.
- 164 funds tracked by Wall St. Rank held Cardlytics as of Q3 2020.
Based on WealthPLAN Partners's 13F filing for Q3 2020, filed 18 Dec 2020.